Reply to Million et al

Clin Infect Dis. 2021 May 4;72(9):e440-e441. doi: 10.1093/cid/ciaa1122.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Drug Treatment*
  • Compassionate Use Trials
  • Humans
  • Hydroxychloroquine*
  • SARS-CoV-2

Substances

  • Hydroxychloroquine